The investment seeks to provide long-term growth of capital primarily through investment in equity securities; current income is a secondary objective... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ROBT | 49.17 | 0.70 | +1.44% |
FT Nasdaq Artfcl Intllgnc and Rbtc ETF | |||
INRO | 29.33 | 0.30 | +1.04% |
iShares U.S. Industry Rotation Act ETF | |||
IHI | 62.30 | 0.14 | +0.23% |
iShares US Medical Devices ETF | |||
ABNY | 11.74 | 0.01 | +0.11% |
YieldMax ABNB Option Income Strategy ETF | |||
BSJU | 26.02 | N/A | N/A |
Invesco BulletShares 2030 HY Corp Bd ETF |
A.I.dvisor indicates that over the last year, JVLCX has been closely correlated with VIVAX. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if JVLCX jumps, then VIVAX could also see price increases.
Ticker / NAME | Correlation To JVLCX | 1D Price Change % | ||
---|---|---|---|---|
JVLCX | 100% | +0.79% | ||
VIVAX - JVLCX | 77% Closely correlated | +0.57% | ||
VIVIX - JVLCX | 77% Closely correlated | +0.57% | ||
VVIAX - JVLCX | 77% Closely correlated | +0.57% | ||
DOXGX - JVLCX | 74% Closely correlated | +0.39% | ||
DODGX - JVLCX | 74% Closely correlated | +0.39% | ||
More |